Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women

Archives of Iranian Medicine

Volumn 17, Issue 4, 2014, Pages 241-245

  Barfar, Eshagh ^a,b   Rashidian, Arash ^a,c   Hosseini, Hamed ^a,c   Nosratnejad, Shirin ^b   Barooti, Esmat ^d   Zendehdel, Kazem ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Cost effectiveness; Iran; Screening

Indexed keywords

ADULT; ARTICLE; ASPIRATION CYTOLOGY; BIOPSY; BREAST CANCER; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; FALSE POSITIVE RESULT; FEMALE; HEALTH PROGRAM; HUMAN; IRAN; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NURSING COST; PROGRAM COST EFFECTIVENESS; SENSITIVITY ANALYSIS; SOCIAL CLASS; AGE; BREAST NEOPLASMS; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; HEALTH CARE COST; LABORATORY DIAGNOSIS; POVERTY; PUBLIC HEALTH;

ADULT; AGE FACTORS; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HEALTH CARE COSTS; HUMANS; IRAN; MAMMOGRAPHY; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; POVERTY; SOCIAL CLASS;

EID: 84899636234     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108.
2. Breast Health Global Initiative. Pan American Health Organization (Regional Office ofthe World Health Organization). 2010; Available from: URL: http://www.paho.org/english/ad/dpc/nc/pcc-bhgi-about.htm.
3. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev. 2004; 5: 24-27.
4. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi A, Harirchi I, Najafi M, et al. Breast cancer in Iran: an epidemiological review. Breast J. 2007; 13: 383-391.
5. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med. 2009; 12: 15-23.
6. Maurer F. A peer education model for teaching breast self-examination to undergraduate college women. Cancer Nurs. 1997; 20: 49-61.
7. Shapiro S, Coleman EA, Broeders M, Codd M, de Koning H, Frache-boud J, et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epidemiol. 1998; 27: 735-742.
8. Barooti E, Haghdoost A, Hosseini H, Tabibzadeh Z, Bahmani S, Taheri S, et al. Vulnerable Household Women's Health Assessment (VH-WHAT): Protocol Design and Implementation. Iran Red Crescent Med J. 2010; 12: 358-364.
9. Statistical Center of Iran. Population by sex in urban and rural areas of the provinces and the cities; 2011. Available from: URL: http://www.amar.org.ir/Portals/2/census-90/shahrestanha-jamiat-90.xlsx
10. Radice D, Redaelli A. Breast cancer management: quality-of-life and cost considerations. Pharmacoeconomics. 2003; 21: 383-396.
11. The Central Bank of Iran. Reference Exchange Rates. 2008; Available from: URL: http://www.cbi.ir/exratesadv/exratesadv_en.aspx
12. Madan J, Rawdin A, Stevenson M, Tappenden P. A Rapid Response Economic Evaluation of the UK NHS Cancer Reform Strategy Breast Cancer Screening Program Extension via a Plausible Bounds Approach. Value in Health. 2010; 13: 215-221.
13. Fletcher SW, Gralow JR, Sokol HN. Screening for breast cancer. UpTo Date. Inc 2010.
14. Nakhaei N, Sadeghi-Hassanabadi A. Cost-effectiveness analysis of Syphilis screening in Shiraz. J Kerman Univ Med Sci. 2000; 7: 65-72.
15. Hossein-nezhad A, Larijani B. Cost analysis of screening and diagnostic methods in gestational diabetes mellitus. Iran J Diabetes and Lipid Disord. 2002; 1: 32-40.
16. Nakhaei N, Divsalar K, Hasibi A. Cost-effectiveness analysis of urine screening for drug of abuse in Kerman Medical University Central Laboratory in 2002.Med J Hormozgan Univ. 2006; 10: 291-295.
17. Forouzanfar M, Karami M, Fotouhi A, Majdzadeh R, Jamali P. Comparison of cost-effectiveness of amblyopia screening by optometrists and trained kindergarten staff. Journal of School of Public Health and Institute of Public Health Research. 2008; 6: 87-99.
18. Rashidian A, Barfar E, Hsosseini H, Nosratnejad S, Barooti E. Cost Effectiveness of Breast Cancer Screening Using Mammography; a Systematic Review. Iran J Public Health 2013; 42: 347-357.
19. Plans P, Casademont L, Salleras L. Cost-effectiveness of breast cancer screening in Spain. Int J Technol Assess Health Care. 1996; 12: 146-150.
20. Lee SY, Jeong SH, Kim YN, Kim J, Kang DR Kim HC, et al. Cost-effective mammography screening in Korea: high incidence of breast cancer in young women. Cancer Sci. 2009; 100: 1105-1111.
21. Denewer A, Hussein O, Farouk O, Elnahas W, Khater A, El-Saed A. Cost-effectiveness of clinical breast assessment-based screening in rural Egypt. World J Surg. 2010; 34: 2204-2210.
22. Norum J. Breast cancer screening by mammography in Norway. Is it cost-effective? Ann Oncol. 1999; 10: 197-203.
23. Fletcher SW, Elmore JG. Mammographic screening for breast cancer. N Engl J Med. 2003; 348: 1672-1680.
24. Michell M. Screening for breast cancer in England: past and future. Sheffield: NHS Cancer Screening Programmes; 2006.
25. De Koning HJ. Mammographic screening: evidence from randomised controlled trials. Ann Oncol. 1999; 14: 1185-1189.
26. Getzsche PC, Jergensen KJ. Screening for breast cancer with mam-mography. Cochrane Database Syst Rev. 2013; 6.